Ear, nose and throat research projects

Through a collaboration with Winclove Probiotics and ENT Technologies the Cervin Group is developing a microbiome therapy nasal spray to treat chronic rhinosinusisits. Preparations are currently underway to test this treatment in humans. 

The Aboriginal and Torres Strait Island population have some of the highest rates of Otitis Media in the world. In collaboration with The Deadly Ears Program the Cervin Group has started a research program exploring the normal bacterial flora in the upper airway in the indigenous population and how it contributes to maintaining health. The aim of this study is to prevent Otitis Media in Aboriginal and Torres Strait Islander children by supplementing the airway with a microbiome therapy. 

For further information download the study brochure.

Radiofrequency ablation is a well-established, effective treatment for reducing troublesome nasal tissue that is offered to patients as an alternative to surgery in the United States and the United kingdom, however, this treatment is rarely used in Australia. This study aims to assess the radiofrequency ablation (RFA) treatment in an Australian hospital setting.